GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aoxing Pharmaceutical Co Inc (OTCPK:AOXG) » Definitions » Change In Receivables

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Change In Receivables : $-10.69 Mil (TTM As of Mar. 2017)


View and export this data going back to 2001. Start your Free Trial

What is Aoxing Pharmaceutical Co Change In Receivables?

Aoxing Pharmaceutical Co's change in receivables for the quarter that ended in Mar. 2017 was $-1.64 Mil. It means Aoxing Pharmaceutical Co's Accounts Receivable increased by $1.64 Mil from Dec. 2016 to Mar. 2017 .

Aoxing Pharmaceutical Co's change in receivables for the fiscal year that ended in Jun. 2016 was $-6.69 Mil. It means Aoxing Pharmaceutical Co's Accounts Receivable increased by $6.69 Mil from Jun. 2015 to Jun. 2016 .

Aoxing Pharmaceutical Co's Accounts Receivable for the quarter that ended in Mar. 2017 was $14.51 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Aoxing Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2017 was 232.13.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Aoxing Pharmaceutical Co's liquidation value for the three months ended in Mar. 2017 was $-25.22 Mil.


Aoxing Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Aoxing Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aoxing Pharmaceutical Co Change In Receivables Chart

Aoxing Pharmaceutical Co Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.76 -0.06 -1.93 -1.74 -6.69

Aoxing Pharmaceutical Co Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.53 -3.06 -2.93 -3.06 -1.64

Aoxing Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aoxing Pharmaceutical Co  (OTCPK:AOXG) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Aoxing Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2017 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=14.505/5.702*91
=232.13

2. In Ben Graham's calculation of liquidation value, Aoxing Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Aoxing Pharmaceutical Co's liquidation value for the quarter that ended in Mar. 2017 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=7.08-44.38+0.75 * 14.505+0.5 * 2.406
=-25.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aoxing Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Aoxing Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Business Description

Traded in Other Exchanges
N/A
Address
624 Tyvola Road, Suite 103, No. 186, Charlotte, NC, USA, 28217
Aoxing Pharmaceutical Co Inc is a specialty pharmaceutical company. The company specializes in research, development, manufacturing, and distribution of a variety of narcotic, pain-management, and addiction treatment pharmaceutical products. Aoxing holds approximately 139 drug production certificates covering narcotic pain-management, exclusive prescription medicines, OTC and API products. It derives all its revenue from the People's Republic of China.
Executives
Wilfred Chow officer: Chief Financial Officer 30 WEST STREET, 3B, NEW YORK NY 10004
John P Oshea director C/O WESTMINSTER SECURITIES CORP, 100 WALL ST, 7TH FLOOR, NEW YORK NY 10005
John Leo director, officer: Secretary 80 WALL STREET, 5TH FLOOR, NEW YORK NY 10005

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Headlines

No Headlines